HomeKRYS • NASDAQ
add
Krystal Biotech Inc
Previous close
$178.41
Year range
$93.95 - $219.34
Market cap
5.13B USD
Avg Volume
228.27K
P/E ratio
48.84
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 70.28M | — |
Operating expense | 43.21M | 13.56% |
Net income | 15.57M | 146.88% |
Net profit margin | 22.15 | — |
Earnings per share | 0.93 | 174.76% |
EBITDA | 22.37M | 160.68% |
Effective tax rate | 2.97% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 559.61M | 17.19% |
Total assets | 917.66M | 34.16% |
Total liabilities | 78.76M | 154.80% |
Total equity | 838.89M | — |
Shares outstanding | 28.73M | — |
Price to book | 6.11 | — |
Return on assets | 5.95% | — |
Return on capital | 6.37% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 15.57M | 146.88% |
Cash from operations | -4.17M | 87.81% |
Cash from investing | -19.35M | -21.28% |
Cash from financing | 10.64M | -94.26% |
Net change in cash | -13.22M | -109.78% |
Free cash flow | -8.16M | 69.12% |
About
Founded
2015
Headquarters
Website
Employees
229
